Insights that advance infection prevention.
New Lab Study Reinforces CHG Efficacy for Skin Antisepsis
A peer-reviewed laboratory evaluation published this quarter adds independent evidence that 2% chlorhexidine gluconate (CHG) in 70% isopropyl alcohol delivers rapid, broad-spectrum skin antisepsis with sustained residual protection.
Study Overview and Methods
The study followed a standardized skin-preparation protocol on healthy adult volunteers and in-vitro microbial panels. Evaluators measured log reduction at multiple time points, tracked the persistence of antimicrobial activity across 48 hours, and recorded tolerability of the formulation on intact skin.
Altogether, more than 1,200 individual test points were collected to model how CHG behaves across the clinical touchpoints most relevant to surgical site prep, vascular access and routine care.
Key Findings
- Fast-acting. More than 99.99% log reduction of common skin flora within 30 seconds of application.
- Broad-spectrum. Effective against staphylococci, enterococci and other organisms frequently implicated in surgical-site infections.
- Persistent. Measurable residual antimicrobial activity retained for up to 48 hours after a single application.
- Well-tolerated. Low irritation scores observed across repeated application cycles on intact skin.
"The results reinforce what clinicians observe every day: CHG does not just clean the site — it creates a persistent antimicrobial environment that lasts."
Clinical Implications
For surgical site preparation, vascular access and catheter maintenance, persistent antisepsis narrows the window for recolonization between application and procedure. Consistent, single-use applicators further reduce cross-contamination risk and support audit-ready, traceable compliance.
Why Hospitals Are Standardizing on CHG
Beyond efficacy, standardized CHG protocols simplify staff training, streamline documentation and deliver reproducible outcomes. As part of a complete skin-preparation workflow, 2% CHG + 70% IPA applicators give care teams a defensible, evidence-based standard of care — from surgical prep to everyday injections.
More Articles
View All News
New Lab Study Reinforces CHG Efficacy for Skin Antisepsis
A new laboratory study reinforces the antimicrobial efficacy of chlorhexidine gluconate skin antisep…
One Formula, Four Formats: Inside the CHG Skin Antiseptic Applicator Range
Press-down, screw-down, snap-type and impregnated swab sticks: one 2% CHG and 70% IPA formula, four…
Single-Use CHG Applicators Cut Skin-Prep Time in Emergency Departments
Single-use CHG applicators shorten skin-prep time in emergency departments while improving applicati…
Audit-Ready Infection Prevention: Digital Tracking Meets CHG Protocols
Combine digital tracking with CHG skin-prep protocols to build audit-ready infection prevention reco…
Standardizing Skin Prep for Injections, IV Lines and Vaccinations
How standardized CHG skin preparation protocols improve injection safety, IV line care and vaccinati…
Ready to Elevate Your Infection Prevention Standards?
Contact our team for product samples, pricing, and regulatory documentation. We support OEM/ODM and global distribution partnerships.